Among 222 BRCA2 PV carriers, 105 individuals (47.3%) were cancer patients, 109 subjects (49.1%) were healthy and 8 individuals (3.6%) were excluded from the study for lack of sufficient information. The gene discussed is BRCA2; the disease is cancer.